HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME

Retrospective research of 381 clinical records is conducted to study HIV infection influence on stationary stage of tuberculosis treatment outcome in HIV-TB co-infected patients. All cases were divided depending on a hospitalization outcome on favorable and adverse. At most of patients tuberculosis...

Full description

Bibliographic Details
Main Authors: A. V. Mordyk, S. V. Sitnikova, L. V. Puzyreva
Format: Article
Language:Russian
Published: Sankt-Peterburg : NIIÈM imeni Pastera 2016-06-01
Series:Инфекция и иммунитет
Subjects:
Online Access:https://www.iimmun.ru/iimm/article/view/388
_version_ 1797973071249801216
author A. V. Mordyk
S. V. Sitnikova
L. V. Puzyreva
author_facet A. V. Mordyk
S. V. Sitnikova
L. V. Puzyreva
author_sort A. V. Mordyk
collection DOAJ
description Retrospective research of 381 clinical records is conducted to study HIV infection influence on stationary stage of tuberculosis treatment outcome in HIV-TB co-infected patients. All cases were divided depending on a hospitalization outcome on favorable and adverse. At most of patients tuberculosis of respiratory organs met. Immunological researches were conducted, the stage of HIV infection was registered and the issue of purpose of anti-retroviral therapy was resolved. Besides, as indirect signs of an immunodeficiency at the patients with a combination of tuberculosis and HIV infection who were on hospitalization the indicators received when carrying out clinical laboratory trials were analyzed: absolute and relative quantity of lymphocytes according to the general blood test, the contents the globulin fractions and circulating immune complexes concentration according to the clinical chemistry blood test. At an assessment of results in both groups of research more than at a half of patients existence of HIV infection at late stages that speaks about late identification and neglect of an immunodeficiency was revealed. At patients with tuberculosis of lungs in combination with HIV infection at a failure statistically significant decrease in an immunoregulatory index is revealed. It is interesting that the level of CD4 lymphocytes and a stage of HIV infection had no impact on the co-infection’s outcome. However, existence of virus loa ding more than 100 000 copies/ml reduced probability favorable an outcome of treatment of tuberculosis at the patient with HIV infection. Timely purpose of anti-retroviral therapy at patients with co-infection increased chances of treatment of tuberculosis at patients with an immunodeficiency. Frequency of adverse side effect of antiviral therapy met equally often at patients in both groups. Thus, patients at any stages of HIV infection with any forms of tuberculosis, including generalized, had a chance to have a favorable outcome of a disease. We consider the reasonable recommendation about carrying out anti-retroviral therapy of patients by all with a combination of tuberculosis and HIV infection, irrespective of the HIV infection stage.
first_indexed 2024-04-11T03:58:24Z
format Article
id doaj.art-5832d7e78f11417cb0295433ae3e24b4
institution Directory Open Access Journal
issn 2220-7619
2313-7398
language Russian
last_indexed 2024-04-11T03:58:24Z
publishDate 2016-06-01
publisher Sankt-Peterburg : NIIÈM imeni Pastera
record_format Article
series Инфекция и иммунитет
spelling doaj.art-5832d7e78f11417cb0295433ae3e24b42023-01-02T00:08:17ZrusSankt-Peterburg : NIIÈM imeni PasteraИнфекция и иммунитет2220-76192313-73982016-06-0161818610.15789/2220-7619-2016-1-81-86283HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOMEA. V. Mordyk0S. V. Sitnikova1L. V. Puzyreva2Omsk State Medical University, Omsk, Russian FederationOmsk State Medical University, Omsk, Russian FederationOmsk State Medical University, Omsk, Russian FederationRetrospective research of 381 clinical records is conducted to study HIV infection influence on stationary stage of tuberculosis treatment outcome in HIV-TB co-infected patients. All cases were divided depending on a hospitalization outcome on favorable and adverse. At most of patients tuberculosis of respiratory organs met. Immunological researches were conducted, the stage of HIV infection was registered and the issue of purpose of anti-retroviral therapy was resolved. Besides, as indirect signs of an immunodeficiency at the patients with a combination of tuberculosis and HIV infection who were on hospitalization the indicators received when carrying out clinical laboratory trials were analyzed: absolute and relative quantity of lymphocytes according to the general blood test, the contents the globulin fractions and circulating immune complexes concentration according to the clinical chemistry blood test. At an assessment of results in both groups of research more than at a half of patients existence of HIV infection at late stages that speaks about late identification and neglect of an immunodeficiency was revealed. At patients with tuberculosis of lungs in combination with HIV infection at a failure statistically significant decrease in an immunoregulatory index is revealed. It is interesting that the level of CD4 lymphocytes and a stage of HIV infection had no impact on the co-infection’s outcome. However, existence of virus loa ding more than 100 000 copies/ml reduced probability favorable an outcome of treatment of tuberculosis at the patient with HIV infection. Timely purpose of anti-retroviral therapy at patients with co-infection increased chances of treatment of tuberculosis at patients with an immunodeficiency. Frequency of adverse side effect of antiviral therapy met equally often at patients in both groups. Thus, patients at any stages of HIV infection with any forms of tuberculosis, including generalized, had a chance to have a favorable outcome of a disease. We consider the reasonable recommendation about carrying out anti-retroviral therapy of patients by all with a combination of tuberculosis and HIV infection, irrespective of the HIV infection stage.https://www.iimmun.ru/iimm/article/view/388tuberculosishiv infectionefficiency of treatmenttuberculosis at hiv-positive people
spellingShingle A. V. Mordyk
S. V. Sitnikova
L. V. Puzyreva
HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
Инфекция и иммунитет
tuberculosis
hiv infection
efficiency of treatment
tuberculosis at hiv-positive people
title HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
title_full HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
title_fullStr HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
title_full_unstemmed HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
title_short HIV INFECTION STAGE, ANTIRETROVIRAL THERAPY SCHEME AND PATIENT IMMUNE STATUS INFLUENCE ON HIV/TB CO-INFECTION OUTCOME
title_sort hiv infection stage antiretroviral therapy scheme and patient immune status influence on hiv tb co infection outcome
topic tuberculosis
hiv infection
efficiency of treatment
tuberculosis at hiv-positive people
url https://www.iimmun.ru/iimm/article/view/388
work_keys_str_mv AT avmordyk hivinfectionstageantiretroviraltherapyschemeandpatientimmunestatusinfluenceonhivtbcoinfectionoutcome
AT svsitnikova hivinfectionstageantiretroviraltherapyschemeandpatientimmunestatusinfluenceonhivtbcoinfectionoutcome
AT lvpuzyreva hivinfectionstageantiretroviraltherapyschemeandpatientimmunestatusinfluenceonhivtbcoinfectionoutcome